UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current status and treatment concept of transcatheter arterial chemoembolization on the era of systemic chemotherapy for hepatocellular carcinoma

Nippon Shokakibyo Gakkai Zasshi, 2022/05/10, Vol.119(5), pp.414-422

UESHIMA, Kazuomi

2022

Volltextzugriff (PDF)

Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)

Digestive diseases (Basel), 2015-10, Vol.33 (6), p.751-758

2015

Volltextzugriff (PDF)

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Liver cancer (Basel ), 2021-06, Vol.10 (3), p.181-223

2021

Volltextzugriff (PDF)

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

Oncology, 2010-07, Vol.78 (Suppl 1), p.154-166

2010

Volltextzugriff (PDF)

Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update

Oncology, 2014-01, Vol.87 (Suppl 1), p.22-31

2014

Volltextzugriff (PDF)

Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study

Hepatology research, 2021-07, Vol.51 (7), p.767-774

2021

Volltextzugriff (PDF)

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Liver cancer (Basel ), 2014-10, Vol.3 (3-4), p.458-468

2014

Volltextzugriff (PDF)

Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)

Hepatology research, 2022-04, Vol.52 (4), p.329-336

2022

Volltextzugriff (PDF)

Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease

Scientific reports, 2021-04, Vol.11 (1), p.9242-9242, Article 9242

2021

Volltextzugriff (PDF)

Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria

Scientific reports, 2022-04, Vol.12 (1), p.6100-6100, Article 6100

2022

Volltextzugriff (PDF)

Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B

Journal of medical virology, 2019-10, Vol.91 (10), p.1804-1810

2019

Volltextzugriff (PDF)

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT

Journal of gastroenterology, 2012-09, Vol.47 (9), p.1036-1047

2012

Volltextzugriff (PDF)

Cold‐inducible RNA‐binding protein promotes the development of liver cancer

Cancer science, 2015-04, Vol.106 (4), p.352-358

2015

Volltextzugriff (PDF)

Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection

Hepatology research, 2022-09, Vol.52 (9), p.754-761

2022

Volltextzugriff (PDF)

Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version)

Hepatology research, 2019-09, Vol.49 (9), p.981-989

2019

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma

Cancer science, 2020-10, Vol.111 (10), p.3759-3769

2020

Volltextzugriff (PDF)

Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma

European radiology, 2018-05, Vol.28 (5), p.1986-1993

2018

Volltextzugriff (PDF)

Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

Journal of hepatology, 2023-01, Vol.78 (1), p.133-141

2023

Volltextzugriff (PDF)

Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound–ultrasound overlay fusion for optimal ablation and local controllability

Hepatology research, 2020-01, Vol.50 (1), p.67-74

2020

Volltextzugriff (PDF)

Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study

Journal of hepato-biliary-pancreatic sciences, 2023-03, Vol.30 (3), p.303-314

2023

Volltextzugriff (PDF)

Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

Hepatology research, 2016-01, Vol.46 (1), p.3-9

2016

Volltextzugriff (PDF)

SY26-3 Systemic chemotherapy for intermediate-stage hepatocellular carcinoma

Annals of oncology, 2021-07, Vol.32, p.S269-S269

Ueshima, Kazuomi

2021

Volltextzugriff (PDF)

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2013-04, Vol.57 (4), p.1407-1415

2013

Volltextzugriff (PDF)

Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience

Digestive diseases (Basel), 2017-01, Vol.35 (6), p.611-617

2017

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(224)

Publikationsform

Artikel
(229)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(128)
Humans
(99)
Hepatocellular Carcinoma
(98)
Male
(81)
Female
(79)
Aged
(74)
Gastroenterology & Hepatology
(72)
Middle Aged
(69)
Oncology
(59)
Liver Cancer
(45)
Adult
(39)
Liver Neoplasms - Pathology
(34)
Aged, 80 And Over
(33)
Treatment Outcome
(32)
Carcinoma, Hepatocellular - Pathology
(30)
Tumors
(30)
Retrospective Studies
(28)
Liver Neoplasms - Drug Therapy
(27)
Sorafenib
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current status and treatment concept of transcatheter arterial chemoembolization on the era of systemic chemotherapy for hepatocellular carcinoma

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update

Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)

Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease

Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria

Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT

Cold‐inducible RNA‐binding protein promotes the development of liver cancer

Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection

Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version)

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma

Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma

Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound–ultrasound overlay fusion for optimal ablation and local controllability

Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study

Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

SY26-3 Systemic chemotherapy for intermediate-stage hepatocellular carcinoma

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience

Suchergebnisse filtern